WATCH: Video summary of the Select Committee's findings on the CCP's role in the American fentanyl epidemic. (Click HERE for a transcript of the video)

WASHINGTON, D.C.-- Chairman Mike Gallagher (R-WI) and Ranking Member Raja Krishnamoorthi (D-IL) of the House Select Committee on the Strategic Competition Between the United States and the Chinese Communist Party wrote to Secretary of Defense Lloyd Austin, alerting him that a Chinese military company, BGI, is attempting to set up a new firm, Innomics, in Massachusetts and Kentucky, to avoid regulatory scrutiny. The lawmakers also identify other problematic Chinese biotech companies in the U.S. that are working to advance the Chinese military and the Chinese Communist Party’s objectives and goals. 

WASHINGTON, D.C.- The House Select Committee on the Chinese Communist Party held a hearing titled "Growing Stakes: The Bioeconomy and American National Security." Witnesses included Dr. Jason Kelly, CEO of Ginkgo Bioworks, Dr. Tara O'Toole, Senior Fellow at In-Q-Tel, and Dr. Charles Clancy, Chief Technology Officer at MITRE

WASHINGTON, D.C.-- Chairman Mike Gallagher (R-WI) of the House Select Committee on the Chinese Communist Party wrote to Attorney General Merrick Garland regarding a U.S. trade group, the Biotechnology Innovation Organization (BIO), lobbying on behalf of Wuxi Apptec, a Chinese company deeply entrenched with the People’s Liberation Army and the Chinese Communist Party. 

Chairman Gallagher asked Attorney General Garland to review BIO’s lobbying on behalf of WuXi Apptec in the context of the Foreign Agent Registration Act.